Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 3697

SAVE Moms and Babies Act of 2026

Refreshed 33 min ago

Introduced 2026-01-27Topic: health care · public health

Summary

AI-generated summary, report an error

This bill would bar the Food and Drug Administration (FDA) from approving any new abortion drug or allowing research testing of abortion drugs. For abortion drugs already approved, the FDA could not approve label changes allowing use after 70 days of pregnancy or allowing dispensing other than in person by the prescriber. These drugs would have to be given in person in a clinic, medical office, or hospital, not in pharmacies, by certified prescribers who meet set requirements. Prescribers, manufacturers, and other health care practitioners would have to report adverse events to the FDA. Existing research exemptions covered by the ban would end 3 years after the bill becomes law.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-01-27SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S292)refer
2026-01-27Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.